Antigen Information
General Information of This Antigen
Antigen ID | TAR0MIBZW |
|||||
---|---|---|---|---|---|---|
Antigen Name | Tumor-associated calcium signal transducer 2 (TACSTD2) |
|||||
Gene Name | TACSTD2 |
|||||
Gene ID | ||||||
Synonym | GA733-1; M1S1; TROP2; Cell surface glycoprotein Trop-2;Membrane component chromosome 1 surface marker 1;Pancreatic carcinoma marker protein GA733-1 |
|||||
Sequence |
MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGS
GMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCN QTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLF RERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRG GLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVITNR RKSGKYKKVEIKELGELRKEPSL Click to Show/Hide
|
|||||
Family | EPCAM family |
|||||
Function |
May function as a growth factor receptor.
Click to Show/Hide
|
|||||
Uniprot Entry | ||||||
HGNC ID | ||||||
KEGG ID |
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
AcLys-vc0101 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
AcLys-vc0101 |
AcLys-vc0101 payload |
Undisclosed |
AcLys-vc0101 linker |
[1] |
AcLys-vcMMAD antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
AcLys-vcMMAD |
AcLys-vcMMAD payload |
Undisclosed |
AcLys-vcMMAD linker |
[1] |
Anti-TROP2 mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
ADC2192 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] |
Anti-TROP2 mAb T6-16
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
TROP2-IR700 |
IRDye 700DX |
Undisclosed |
Undisclosed |
[3] |
C6vc0101 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
C6vc0101 |
C6vc0101 payload |
Undisclosed |
C6vc0101 linker |
[1] |
C6vcMMAD antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
C6vcMMAD |
C6vcMMAD payload |
Undisclosed |
C6vcMMAD linker |
[1] |
CN106795203B_ADC-12 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-12 |
CN106795203B_ADC-12 payload |
Undisclosed |
CN106795203B_ADC-12 linker |
[1] |
CN106795203B_ADC-13 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-13 |
CN106795203B_ADC-13 payload |
Undisclosed |
CN106795203B_ADC-13 linker |
[1] |
CN106795203B_ADC-14 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-14 |
CN106795203B_ADC-14 payload |
Undisclosed |
CN106795203B_ADC-14 linker |
[1] |
CN106795203B_ADC-15 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-15 |
CN106795203B_ADC-15 payload |
Undisclosed |
CN106795203B_ADC-15 linker |
[1] |
CN106795203B_ADC-16 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-16 |
CN106795203B_ADC-16 payload |
Undisclosed |
CN106795203B_ADC-16 linker |
[1] |
CN106795203B_ADC-17 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-17 |
CN106795203B_ADC-17 payload |
Undisclosed |
CN106795203B_ADC-17 linker |
[1] |
CN106795203B_ADC-18 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-18 |
CN106795203B_ADC-18 payload |
Undisclosed |
CN106795203B_ADC-18 linker |
[1] |
CN106795203B_ADC-19 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-19 |
CN106795203B_ADC-19 payload |
Undisclosed |
CN106795203B_ADC-19 linker |
[1] |
CN106795203B_ADC-49 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-49 |
CN106795203B_ADC-49 payload |
Undisclosed |
CN106795203B_ADC-49 linker |
[1] |
CN106795203B_ADC-50 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-50 |
CN106795203B_ADC-50 payload |
Undisclosed |
CN106795203B_ADC-50 linker |
[1] |
CN106795203B_ADC-51 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-51 |
CN106795203B_ADC-51 payload |
Undisclosed |
CN106795203B_ADC-51 linker |
[1] |
CN106795203B_ADC-52 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-52 |
CN106795203B_ADC-52 payload |
Undisclosed |
CN106795203B_ADC-52 linker |
[1] |
CN106795203B_ADC-53 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-53 |
CN106795203B_ADC-53 payload |
Undisclosed |
CN106795203B_ADC-53 linker |
[1] |
CN106795203B_ADC-54 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-54 |
CN106795203B_ADC-54 payload |
Undisclosed |
CN106795203B_ADC-54 linker |
[1] |
CN106795203B_ADC-55 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-55 |
CN106795203B_ADC-55 payload |
Undisclosed |
CN106795203B_ADC-55 linker |
[1] |
CN106795203B_ADC-56 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-56 |
CN106795203B_ADC-56 payload |
Undisclosed |
CN106795203B_ADC-56 linker |
[1] |
CN106795203B_ADC-57 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-57 |
CN106795203B_ADC-57 payload |
Undisclosed |
CN106795203B_ADC-57 linker |
[1] |
CN106795203B_ADC-58 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-58 |
CN106795203B_ADC-58 payload |
Undisclosed |
CN106795203B_ADC-58 linker |
[1] |
CN106795203B_ADC-59 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-59 |
CN106795203B_ADC-59 payload |
Undisclosed |
CN106795203B_ADC-59 linker |
[1] |
CN106795203B_ADC-60 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-60 |
CN106795203B_ADC-60 payload |
Undisclosed |
CN106795203B_ADC-60 linker |
[1] |
CN106795203B_ADC-61 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-61 |
CN106795203B_ADC-61 payload |
Undisclosed |
CN106795203B_ADC-61 linker |
[1] |
CN106795203B_ADC-62 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-62 |
CN106795203B_ADC-62 payload |
Undisclosed |
CN106795203B_ADC-62 linker |
[1] |
CN106795203B_ADC-63 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-63 |
CN106795203B_ADC-63 payload |
Undisclosed |
CN106795203B_ADC-63 linker |
[1] |
CN106795203B_ADC-64 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-64 |
CN106795203B_ADC-64 payload |
Undisclosed |
CN106795203B_ADC-64 linker |
[1] |
CN106795203B_ADC-65 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-65 |
CN106795203B_ADC-65 payload |
Undisclosed |
CN106795203B_ADC-65 linker |
[1] |
CN106795203B_ADC-66 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-66 |
CN106795203B_ADC-66 payload |
Undisclosed |
CN106795203B_ADC-66 linker |
[1] |
CN106795203B_ADC-67 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-67 |
CN106795203B_ADC-67 payload |
Undisclosed |
CN106795203B_ADC-67 linker |
[1] |
CN106795203B_ADC-68 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-68 |
CN106795203B_ADC-68 payload |
Undisclosed |
CN106795203B_ADC-68 linker |
[1] |
CN106795203B_ADC-69 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-69 |
CN106795203B_ADC-69 payload |
Undisclosed |
CN106795203B_ADC-69 linker |
[1] |
CN106795203B_ADC-70 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-70 |
CN106795203B_ADC-70 payload |
Undisclosed |
CN106795203B_ADC-70 linker |
[1] |
CN106795203B_ADC-71 antibody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CN106795203B ADC-71 |
CN106795203B_ADC-71 payload |
Undisclosed |
CN106795203B_ADC-71 linker |
[1] |
Datopotamab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Datopotamab deruxtecan |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[4] | |
Datopotamab-ADC-Tb2-1 |
Datopotamab-ADC-Tb2-1 payload |
Undisclosed |
Datopotamab-ADC-Tb2-1 linker |
[5] | |
Datopotamab-ADC-Tb2-2 |
Datopotamab-ADC-Tb2-2 payload |
Undisclosed |
Datopotamab-ADC-Tb2-2 linker |
[5] | |
Datopotamab-ADC-Tb2-3 |
Datopotamab-ADC-Tb2-3 payload |
Undisclosed |
Datopotamab-ADC-Tb2-3 linker |
[5] | |
Datopotamab-ADC-Tb2-4 |
Datopotamab-ADC-Tb2-4 payload |
Undisclosed |
Datopotamab-ADC-Tb2-4 linker |
[5] | |
Datopotamab-ADC-Tb2-5 |
Datopotamab-ADC-Tb2-5 payload |
Undisclosed |
Datopotamab-ADC-Tb2-5 linker |
[5] | |
Datopotamab-ADC-Tb2-6 |
Datopotamab-ADC-Tb2-6 payload |
Undisclosed |
Datopotamab-ADC-Tb2-6 linker |
[5] | |
Datopotamab-ADC-Tb2-7 |
Datopotamab-ADC-Tb2-7 payload |
Undisclosed |
Datopotamab-ADC-Tb2-7 linker |
[5] | |
Datopotamab-ADC-Tb2-8 |
Datopotamab-ADC-Tb2-8 payload |
Undisclosed |
Datopotamab-ADC-Tb2-8 linker |
[5] | |
Datopotamab-ADC-Tb2-9 |
Datopotamab-ADC-Tb2-9 payload |
Undisclosed |
Datopotamab-ADC-Tb2-9 linker |
[5] | |
Datopotamab-ADC-Tb2-10 |
Datopotamab-ADC-Tb2-10 payload |
Undisclosed |
Datopotamab-ADC-Tb2-10 linker |
[5] |
hRS7
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2021147993A1 ADC-6 |
WO2021147993A1 ADC-6 payload |
Undisclosed |
WO2021147993A1 ADC-6 linker |
[6] | |
WO2021147993A1 ADC-7 |
WO2021147993A1 ADC-7 payload |
Undisclosed |
WO2021147993A1 ADC-7 linker |
[6] | |
WO2021147993A1 ADC-8 |
WO2021147993A1 ADC-8 payload |
Undisclosed |
WO2021147993A1 ADC-8 linker |
[6] |
Humanized Anti-Trop-2 hIgG1 Anti-ody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
RN927C |
Auristatin 0101 |
Microtubule (MT) |
AcLys-Val-Cit-PABC |
[7] |
PD3
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2021147993A1 ADC-1 |
WO2021147993A1 ADC-1 payload |
Undisclosed |
WO2021147993A1 ADC-1 linker |
[6] | |
WO2021147993A1 ADC-2 |
WO2021147993A1 ADC-2 payload |
Undisclosed |
WO2021147993A1 ADC-2 linker |
[6] | |
WO2021147993A1 ADC-3 |
WO2021147993A1 ADC-3 payload |
Undisclosed |
WO2021147993A1 ADC-3 linker |
[6] | |
WO2021147993A1 ADC-5 |
WO2021147993A1 ADC-5 payload |
Undisclosed |
WO2021147993A1 ADC-5 linker |
[6] |
PF-06478924
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PF-06664178 |
Auristatin 0101 |
Microtubule (MT) |
AcLys-Val-Cit-PABC |
[8] |
Sacituzumab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Sacituzumab govitecan |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
[9] | |
SKB-264 |
KL610023 |
DNA topoisomerase 1 (TOP1) |
Pyrimidine-CL2A-carbonate |
[10] | |
ESG-401 |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[11] | |
PBX-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
Trop2-ADC-01 (DAR8) |
Trop2-ADC-01(DAR8) payload |
Undisclosed |
Trop2-ADC-01(DAR8) linker |
[5] | |
Trop2-ADC-02 (DAR8) |
Trop2-ADC-02(DAR8) payload |
Undisclosed |
Trop2-ADC-02(DAR8) linker |
[5] | |
Trop2-ADC-03 (DAR8) |
Trop2-ADC-03(DAR8) payload |
Undisclosed |
Trop2-ADC-03(DAR8) linker |
[5] | |
Trop2-ADC-04 (DAR8) |
Trop2-ADC-04(DAR8) payload |
Undisclosed |
Trop2-ADC-04(DAR8) linker |
[5] | |
Trop2-ADC-05 (DAR8) |
Trop2-ADC-05(DAR8) payload |
Undisclosed |
Trop2-ADC-05(DAR8) linker |
[5] | |
Trop2-ADC-06 (DAR8) |
Trop2-ADC-06(DAR8) payload |
Undisclosed |
Trop2-ADC-06(DAR8) linker |
[5] | |
Trop2-ADC-08 (DAR8) |
Trop2-ADC-08(DAR8) payload |
Undisclosed |
Trop2-ADC-08(DAR8) linker |
[5] | |
Trop2-ADC-09 (DAR8) |
Trop2-ADC-09(DAR8) payload |
Undisclosed |
Trop2-ADC-09(DAR8) linker |
[5] | |
Trop2-ADC-10 (DAR8) |
Trop2-ADC-10(DAR8) payload |
Undisclosed |
Trop2-ADC-10(DAR8) linker |
[5] | |
Sacituzumab-Compound (Ia) |
NeoDegrader P1 |
Protein cereblon (CRBN) |
Sacituzumab-Compound (Ia) linker |
[13] | |
ADC-II-3 |
ADC-II-3 payload |
Undisclosed |
ADC-II-3 linker |
[14] | |
ADC-II-7 |
ADC-II-7 payload |
Undisclosed |
ADC-II-7 linker |
[14] | |
ADC-II-11-a |
ADC-II-11-a payload |
Undisclosed |
ADC-II-11-a linker |
[14] | |
ADC-II-15 |
ADC-II-15 payload |
Undisclosed |
ADC-II-15 linker |
[14] | |
ADC-III-3 |
ADC-III-3 payload |
Undisclosed |
ADC-III-3 linker |
[14] | |
ADC-III-11 |
ADC-III-11 payload |
Undisclosed |
ADC-III-11 linker |
[14] | |
ADC-II-11-b |
ADC-II-11-b payload |
Undisclosed |
ADC-II-11-b linker |
[14] | |
ADC-II-53 |
ADC-II-53 payload |
Undisclosed |
ADC-II-53 linker |
[14] | |
ADC-II-57 |
ADC-II-57 payload |
Undisclosed |
ADC-II-57 linker |
[14] | |
ADC-III-28 |
ADC-III-28 payload |
Undisclosed |
ADC-III-28 linker |
[14] | |
ADC-III-33 |
ADC-III-33 payload |
Undisclosed |
ADC-III-33 linker |
[14] | |
Sacituzumab-Deruxtecan |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[14] | |
Trop2-ADC-07 (DAR8) |
Trop2-ADC-07(DAR8) payload |
Undisclosed |
Trop2-ADC-07(DAR8) linker |
[5] | |
WO2022228495A1 ADC-76 |
WO2022228495A1 ADC-76 payload |
Undisclosed |
WO2022228495A1 ADC-76 linker |
[15] | |
WO2022228495A1 ADC-77 |
WO2022228495A1 ADC-77 payload |
Undisclosed |
WO2022228495A1 ADC-77 linker |
[15] | |
WO2022228495A1 ADC-78 |
WO2022228495A1 ADC-78 payload |
Undisclosed |
WO2022228495A1 ADC-78 linker |
[15] | |
Sacituzumab-SN-38 |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
[16] | |
Sacituzumab-Compound 9 |
Mertansine DM1 |
Microtubule (MT) |
Sacituzumab-Compound 9 linker |
[17] | |
Sacituzumab-Compound 17 |
Mertansine DM4 |
Microtubule (MT) |
Sacituzumab-Compound 17 linker |
[17] | |
Sacituzumab-Compound 25 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 25 linker |
[17] | |
Sacituzumab-Compound 31 |
Auristatin 0101 |
Microtubule (MT) |
Sacituzumab-Compound 31 linker |
[17] | |
Sacituzumab-Compound 36 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 36 linker |
[17] | |
Sacituzumab-Compound 43 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Sacituzumab-Compound 43 linker |
[17] | |
Sacituzumab-Compound 49 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Sacituzumab-Compound 49 linker |
[17] | |
Sacituzumab-Compound 55 |
Mertansine DM1 |
Microtubule (MT) |
Sacituzumab-Compound 55 linker |
[17] | |
Sacituzumab-Compound 59 |
Mertansine DM4 |
Microtubule (MT) |
Sacituzumab-Compound 59 linker |
[17] | |
Sacituzumab-Compound 64 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 64 linker |
[17] | |
Sacituzumab-Compound 69 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 69 linker |
[17] | |
Sacituzumab-Compound 74 |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Sacituzumab-Compound 74 linker |
[17] | |
Sacituzumab-Compound 75 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 75 linker |
[17] | |
Sacituzumab-Compound 76 |
Monomethyl auristatin E |
Microtubule (MT) |
Sacituzumab-Compound 76 linker |
[17] | |
Sacituzumab-Compound 77 |
Mertansine DM1 |
Microtubule (MT) |
Sacituzumab-Compound 77 linker |
[17] | |
Sacituzumab-Compound 78 |
Auristatin 0101 |
Microtubule (MT) |
Sacituzumab-Compound 78 linker |
[17] | |
Sacituzumab-Compound 79 |
Auristatin 0101 |
Microtubule (MT) |
Sacituzumab-Compound 79 linker |
[17] | |
Sacituzumab-Compound 80 |
Mertansine DM4 |
Microtubule (MT) |
Sacituzumab-Compound 80 linker |
[17] |
TINA
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2021147993A1 ADC-4 |
WO2021147993A1 ADC-4 payload |
Undisclosed |
WO2021147993A1 ADC-4 linker |
[6] | |
WO2021147993A1 ADC-9 |
WO2021147993A1 ADC-9 payload |
Undisclosed |
WO2021147993A1 ADC-9 linker |
[6] |
Undisclosed
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
DB-1305 |
P1003 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[18] | |
SHR-A1921 |
SHR9265 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[19] | |
BIO-106 |
Undisclosed |
Undisclosed |
Undisclosed |
[20] | |
MHB036C |
Topoisomerase I inhibitor |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[21] | |
BAT-8008 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
BL-M02D1 |
Undisclosed |
Undisclosed |
Undisclosed |
[23] | |
DAC-002 |
Undisclosed |
Undisclosed |
Undisclosed |
[24] | |
FDA-018 |
Undisclosed |
Undisclosed |
Undisclosed |
[25] | |
Recombinant humanized anti-Trop2 antibody |
Undisclosed |
Undisclosed |
Undisclosed |
[26] | |
YL202 |
Undisclosed |
Undisclosed |
Undisclosed |
[27] | |
9MW-2921 |
Topoisomerase I inhibitor |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[28] | |
FZ-AD004 |
Undisclosed |
Undisclosed |
Undisclosed |
[29] | |
Humanized anti-TROP2-SN38 antibody conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[30] | |
R4702 |
Undisclosed |
Undisclosed |
Undisclosed |
[31] | |
DXC-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[24] | |
GQ-1003 |
Undisclosed |
Undisclosed |
Undisclosed |
[32] | |
BSI-04702 |
Undisclosed |
Undisclosed |
Undisclosed |
[33] | |
DpADC |
Topo1 inhibitor+immune agonist |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[34] | |
LCB-84 |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
[35] | |
Anti-TROP2 ADC (Lanier) |
Undisclosed |
Undisclosed |
Undisclosed |
[36] | |
BAT-8003 |
Maytansinoid derivative |
Microtubule (MT) |
Uncleavable linker |
[37] | |
Anti-TROP2 ADC (XDCExplorer) |
Undisclosed |
Undisclosed |
Undisclosed |
[38] |
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Bacterial infection [ICD-11: 1A00-1C4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Bacterial infection of gingival | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.646003732; Fold-change: 0.02005813; Z-score: 0.104342136 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 02
Brain cancer [ICD-11: 2A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Brainstem | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.860929017; Fold-change: -0.121771864; Z-score: -0.248138211 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | White matter | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000246098; Fold-change: -0.757520251; Z-score: -2.034875933 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Brainstem | |
The Specific Disease | Neuroectodermal tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.02147792; Fold-change: -0.177238287; Z-score: -1.182758318 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Nervous | |
The Specific Disease | Brain cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 5.31E-20; Fold-change: -0.120295595; Z-score: -0.607883179 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic myeloid leukemia [ICD-11: 2A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Polycythemia vera | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.045121825; Fold-change: 0.0769918; Z-score: 0.577978813 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Whole blood | |
The Specific Disease | Myelofibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.786287453; Fold-change: -0.019383026; Z-score: -0.156995689 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
MyeloDysplastic syndromes [ICD-11: 2A37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myelodysplastic syndromes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.153912727; Fold-change: 0.069573148; Z-score: 0.311027408 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.02344139; Fold-change: 0.099187066; Z-score: 1.295646269 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lymphoma [ICD-11: 2A90- 2A85]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Tonsil | |
The Specific Disease | Lymphoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.747715931; Fold-change: -0.064636806; Z-score: -0.532557963 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Gastric cancer [ICD-11: 2B72]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric | |
The Specific Disease | Gastric cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.860965989; Fold-change: -0.031569624; Z-score: -0.363157552 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.983354219; Fold-change: 0.012789259; Z-score: 0.05877818 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Colon cancer [ICD-11: 2B90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon | |
The Specific Disease | Colon cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.16E-19; Fold-change: 0.234394083; Z-score: 0.976617871 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.454131877; Fold-change: 0.017840273; Z-score: 0.060252076 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pancreatic cancer [ICD-11: 2C10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pancreas | |
The Specific Disease | Pancreatic cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.032162447; Fold-change: -0.191004657; Z-score: -0.863191043 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 9.44E-05; Fold-change: -0.245019937; Z-score: -0.731956798 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver cancer [ICD-11: 2C12]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.87E-18; Fold-change: -0.608712001; Z-score: -2.505996726 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 4.06E-88; Fold-change: -0.610862193; Z-score: -2.858492514 | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.00528615; Fold-change: -0.570033126; Z-score: -3.96108538 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lung cancer [ICD-11: 2C25]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Lung cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.00055185; Fold-change: 0.060675065; Z-score: 0.31092763 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.904195475; Fold-change: -0.00021585; Z-score: -0.000945757 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Melanoma [ICD-11: 2C30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Melanoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.00155708; Fold-change: -0.400040853; Z-score: -0.820529974 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sarcoma [ICD-11: 2C35]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Sarcoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000261883; Fold-change: 0.058912068; Z-score: 0.261989945 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.566217999; Fold-change: -0.033960636; Z-score: -0.278110988 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Breast cancer [ICD-11: 2C60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Breast | |
The Specific Disease | Breast cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.848801339; Fold-change: 0.01049881; Z-score: 0.041504994 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.430283007; Fold-change: -0.043752942; Z-score: -0.155416008 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ovarian cancer [ICD-11: 2C73]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Ovarian | |
The Specific Disease | Ovarian cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.599278238; Fold-change: 0.03145742; Z-score: 0.093963239 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.000895596; Fold-change: 0.142403641; Z-score: 1.187750535 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cervical cancer [ICD-11: 2C77]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Cervical | |
The Specific Disease | Cervical cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.01257321; Fold-change: -0.121305273; Z-score: -0.820775723 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Uterine cancer [ICD-11: 2C78]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Uterine cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.47E-11; Fold-change: 0.197743186; Z-score: 0.81638737 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.063727968; Fold-change: 0.145029655; Z-score: 1.059202896 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Prostate cancer [ICD-11: 2C82]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Prostate | |
The Specific Disease | Prostate cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.22E-08; Fold-change: 0.826805512; Z-score: 1.72169731 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Bladder cancer [ICD-11: 2C94]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Bladder cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.017547574; Fold-change: 0.177486888; Z-score: 1.415257041 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Retina cancer [ICD-11: 2D02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Uvea | |
The Specific Disease | Retinoblastoma tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.525036887; Fold-change: -0.080833151; Z-score: -0.616793808 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thyroid cancer [ICD-11: 2D10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Thyroid | |
The Specific Disease | Thyroid cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000655815; Fold-change: 0.062278488; Z-score: 0.294286473 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.118167386; Fold-change: 0.112127674; Z-score: 0.445768548 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Adrenal cancer [ICD-11: 2D11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adrenal cortex | |
The Specific Disease | Adrenocortical carcinoma | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.001281225; Fold-change: -0.099728738; Z-score: -0.468852749 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Head and neck cancer [ICD-11: 2D42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Head and neck | |
The Specific Disease | Head and neck cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.033873507; Fold-change: -0.043109712; Z-score: -0.187280283 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pituitary cancer [ICD-11: 2F37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary gonadotrope tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.937995389; Fold-change: 0.020318056; Z-score: 0.2198227 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.089959363; Fold-change: 0.062078978; Z-score: 0.486864118 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 03
Thrombocytopenia [ICD-11: 3B64]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.466524531; Fold-change: 0.135191888; Z-score: 0.99910311 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 04
Lupus erythematosus [ICD-11: 4A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Lupus erythematosus | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.4657422; Fold-change: -0.091897705; Z-score: -0.234721636 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autoimmune disease [ICD-11: 4A4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral monocyte | |
The Specific Disease | Autoimmune uveitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.009963869; Fold-change: -0.201762636; Z-score: -1.098354132 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 05
Hyperlipoproteinaemia [ICD-11: 5C80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Familial hypercholesterolemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.959433282; Fold-change: -0.018777131; Z-score: -0.060103424 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 06
Schizophrenia [ICD-11: 6A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Superior temporal cortex | |
The Specific Disease | Schizophrenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.205354038; Fold-change: -0.05651575; Z-score: -0.537465229 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 08
Multiple sclerosis [ICD-11: 8A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Spinal cord | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.874623063; Fold-change: -0.123054734; Z-score: -1.181671231 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Plasmacytoid dendritic cells | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.619291188; Fold-change: 0.020810969; Z-score: 0.09683439 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Epilepsy [ICD-11: 8A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peritumoral cortex | |
The Specific Disease | Epilepsy | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.235364418; Fold-change: -0.01802855; Z-score: -0.103354409 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cerebral ischaemic stroke [ICD-11: 8B11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Cardioembolic Stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.015177009; Fold-change: 0.231597676; Z-score: 0.721031236 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Ischemic stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.13507681; Fold-change: 0.053476596; Z-score: 0.18935571 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 1
HIV [ICD-11: 1C60-1C62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | White matter | |
The Specific Disease | HIV | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.183644388; Fold-change: -0.011078298; Z-score: -0.048035772 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Influenza [ICD-11: 1E30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Influenza | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.68302535; Fold-change: 0.166100001; Z-score: 0.612290876 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic hepatitis C [ICD-11: 1E51.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Chronic hepatitis C | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.592682113; Fold-change: 0.017226339; Z-score: 0.181984871 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sepsis [ICD-11: 1G40-1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Sepsis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.23E-08; Fold-change: 0.158915165; Z-score: 0.683076848 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Septic shock [ICD-11: 1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Septic shock | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.68E-25; Fold-change: 0.358246066; Z-score: 1.397439169 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Pediatric respiratory syncytial virus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.19488862; Fold-change: 0.158527747; Z-score: 0.798212051 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 11
Essential hypertension [ICD-11: BA00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Essential hypertension | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.967678461; Fold-change: 0.113411252; Z-score: 3.521072561 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myocardial infarction [ICD-11: BA41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myocardial infarction | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.020199876; Fold-change: 0.220375809; Z-score: 0.474346434 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Coronary artery disease [ICD-11: BA8Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Coronary artery disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.211195737; Fold-change: -0.052552312; Z-score: -0.505916764 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aortic stenosis [ICD-11: BB70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Calcified aortic valve | |
The Specific Disease | Aortic stenosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.548670066; Fold-change: -0.149540921; Z-score: -0.478661794 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arteriosclerosis [ICD-11: BD40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arteriosclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.864890603; Fold-change: -0.019731596; Z-score: -0.076530094 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aneurysm [ICD-11: BD50]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Intracranial artery | |
The Specific Disease | Aneurysm | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.20242167; Fold-change: -0.072310084; Z-score: -0.68167151 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 12
Immunodeficiency [ICD-11: 4A00-4A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Immunodeficiency | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.031816868; Fold-change: 0.106330694; Z-score: 1.158559696 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Apnea [ICD-11: 7A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Hyperplastic tonsil | |
The Specific Disease | Apnea | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.90178899; Fold-change: -0.263636723; Z-score: -1.23697409 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Olive pollen allergy [ICD-11: CA08.00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Olive pollen allergy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.34853716; Fold-change: 0.10169276; Z-score: 0.407916442 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic rhinosinusitis [ICD-11: CA0A]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Sinus mucosa | |
The Specific Disease | Chronic rhinosinusitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.097056368; Fold-change: 0.120899246; Z-score: 0.788816175 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic obstructive pulmonary disease [ICD-11: CA22]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.461457902; Fold-change: -0.01082863; Z-score: -0.054646571 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Small airway epithelium | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000786034; Fold-change: 0.146735236; Z-score: 0.849639215 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Asthma [ICD-11: CA23]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal and bronchial airway | |
The Specific Disease | Asthma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.070361966; Fold-change: 0.382843432; Z-score: 0.430802637 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Human rhinovirus infection [ICD-11: CA42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal Epithelium | |
The Specific Disease | Human rhinovirus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.480486248; Fold-change: -0.017291686; Z-score: -0.119182819 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Idiopathic pulmonary fibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.066611112; Fold-change: -0.157101714; Z-score: -1.183812052 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 13
Periodontal disease [ICD-11: DA0C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Periodontal disease | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.443421089; Fold-change: -0.027619194; Z-score: -0.145580093 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Eosinophilic gastritis [ICD-11: DA42.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric antrum | |
The Specific Disease | Eosinophilic gastritis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.170953924; Fold-change: 0.116475104; Z-score: 1.094063062 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver failure [ICD-11: DB99.7-DB99.8]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver failure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.421809104; Fold-change: 0.002833709; Z-score: 0.0175548 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ulcerative colitis [ICD-11: DD71]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon mucosal | |
The Specific Disease | Ulcerative colitis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.635855799; Fold-change: 0.065278367; Z-score: 0.242126494 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Irritable bowel syndrome [ICD-11: DD91.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Irritable bowel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.259773766; Fold-change: -0.037337221; Z-score: -0.181666724 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 14
Atopic dermatitis [ICD-11: EA80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Atopic dermatitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000623516; Fold-change: -0.116117804; Z-score: -1.288980192 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Psoriasis [ICD-11: EA90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Psoriasis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.62E-08; Fold-change: 0.293996088; Z-score: 0.801657998 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.75268022; Fold-change: -0.01739102; Z-score: -0.042207256 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Vitiligo [ICD-11: ED63.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Vitiligo | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.488409745; Fold-change: -0.013237104; Z-score: -0.073336526 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alopecia [ICD-11: ED70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin from scalp | |
The Specific Disease | Alopecia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.003007082; Fold-change: -0.168749204; Z-score: -0.506585611 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sensitive skin [ICD-11: EK0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Sensitive skin | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.134101564; Fold-change: 0.094520679; Z-score: 0.77941183 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 15
Osteoarthritis [ICD-11: FA00-FA0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Osteoarthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.178042747; Fold-change: -0.084085503; Z-score: -0.383245002 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthropathy [ICD-11: FA00-FA5Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthropathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.521321498; Fold-change: 0.129542698; Z-score: 0.416118973 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.852167133; Fold-change: -0.073314329; Z-score: -0.273773561 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rheumatoid arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Rheumatoid arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.001154467; Fold-change: -0.403906279; Z-score: -2.428000076 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ankylosing spondylitis [ICD-11: FA92.0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pheripheral blood | |
The Specific Disease | Ankylosing spondylitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.121041237; Fold-change: -0.048218715; Z-score: -0.448595181 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Osteoporosis [ICD-11: FB83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Osteoporosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.582699634; Fold-change: -0.152244985; Z-score: -0.560662269 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 16
Endometriosis [ICD-11: GA10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Endometriosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.237972269; Fold-change: 0.103723969; Z-score: 0.390020876 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Interstitial cystitis [ICD-11: GC00.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Interstitial cystitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.449841987; Fold-change: -0.078865333; Z-score: -1.092104911 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 19
Preterm birth [ICD-11: KA21.4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Myometrium | |
The Specific Disease | Preterm birth | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.755964768; Fold-change: -0.051468298; Z-score: -0.251055381 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 2
Acute myelocytic leukemia [ICD-11: 2A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Acute myelocytic leukemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.035929484; Fold-change: -0.017973558; Z-score: -0.075712205 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myeloma [ICD-11: 2A83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.754692186; Fold-change: -0.029477216; Z-score: -0.339215688 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.331931739; Fold-change: -0.04968298; Z-score: -0.269897304 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Oral cancer [ICD-11: 2B6E]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Oral | |
The Specific Disease | Oral cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 2.63E-06; Fold-change: -0.296823023; Z-score: -1.275806007 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.002042436; Fold-change: -0.084873377; Z-score: -0.294510313 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Esophagal cancer [ICD-11: 2B70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Esophagus | |
The Specific Disease | Esophagal cancer | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.001701951; Fold-change: -0.463484352; Z-score: -2.814378182 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rectal cancer [ICD-11: 2B92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Rectal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.207515955; Fold-change: 0.198736903; Z-score: 0.96681527 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.914503668; Fold-change: 0.024889823; Z-score: 0.080401531 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Skin cancer [ICD-11: 2C30-2C3Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Skin cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.55E-31; Fold-change: -0.537265817; Z-score: -1.432572789 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.11E-23; Fold-change: -0.627952675; Z-score: -1.132475425 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Renal cancer [ICD-11: 2C90-2C91]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Kidney | |
The Specific Disease | Renal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.00483207; Fold-change: -0.309130357; Z-score: -1.532039343 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 7.19E-28; Fold-change: -0.453385437; Z-score: -2.020541088 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ureter cancer [ICD-11: 2C92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Urothelium | |
The Specific Disease | Ureter cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.685295868; Fold-change: 0.011574557; Z-score: 0.08755066 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 20
Simpson golabi behmel syndrome [ICD-11: LD2C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adipose | |
The Specific Disease | Simpson golabi behmel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.12293909; Fold-change: 0.071545773; Z-score: 0.880288148 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Tuberous sclerosis complex [ICD-11: LD2D.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Perituberal | |
The Specific Disease | Tuberous sclerosis complex | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.16344363; Fold-change: 0.251185468; Z-score: 1.167433398 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 3
Anemia [ICD-11: 3A00-3A9Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Anemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.713856233; Fold-change: 0.046770081; Z-score: 0.226070042 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Sickle cell disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.481139088; Fold-change: 0.070283558; Z-score: 0.356491361 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thrombocythemia [ICD-11: 3B63]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocythemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.685824948; Fold-change: -0.030142767; Z-score: -0.23211535 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 4
Scleroderma [ICD-11: 4A42.Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Scleroderma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.727161659; Fold-change: -0.075131185; Z-score: -0.156485899 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sjogren syndrome [ICD-11: 4A43]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Salivary gland | |
The Specific Disease | Sjogren syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.205944381; Fold-change: -0.321823967; Z-score: -1.238248636 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.0360331; Fold-change: -0.293650716; Z-score: -2.280971814 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Behcet disease [ICD-11: 4A62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Behcet disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.977293134; Fold-change: 0.02692613; Z-score: 0.084008119 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autosomal dominant monocytopenia [ICD-11: 4B04]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autosomal dominant monocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.686444908; Fold-change: 0.010956123; Z-score: 0.077316942 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 5
Type 2 diabetes [ICD-11: 5A11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Type 2 diabetes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.312088257; Fold-change: -0.025965167; Z-score: -0.256695555 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Polycystic ovary syndrome [ICD-11: 5A80.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Vastus lateralis muscle | |
The Specific Disease | Polycystic ovary syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.352269551; Fold-change: 0.080417634; Z-score: 0.693726536 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Obesity [ICD-11: 5B81]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Subcutaneous Adipose | |
The Specific Disease | Obesity | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.371508991; Fold-change: -0.000305341; Z-score: -0.001936737 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pompe disease [ICD-11: 5C51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Biceps muscle | |
The Specific Disease | Pompe disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.374784036; Fold-change: -0.012090491; Z-score: -0.151685242 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Batten disease [ICD-11: 5C56.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Batten disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.096807504; Fold-change: 0.646134778; Z-score: 1.37762977 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 6
Autism [ICD-11: 6A02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autism | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.186814943; Fold-change: 0.083428594; Z-score: 0.298093773 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Anxiety disorder [ICD-11: 6B00-6B0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Anxiety disorder | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.030404127; Fold-change: 0.309518825; Z-score: 0.796949303 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 8
Parkinson disease [ICD-11: 8A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Substantia nigra | |
The Specific Disease | Parkinson disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.412309285; Fold-change: 0.149830631; Z-score: 0.954388748 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Huntington disease [ICD-11: 8A01]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Huntington disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.253668926; Fold-change: 0.080115972; Z-score: 0.290992463 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alzheimer disease [ICD-11: 8A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Entorhinal cortex | |
The Specific Disease | Alzheimer disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.46E-05; Fold-change: -0.049002687; Z-score: -0.275235133 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Seizure [ICD-11: 8A60-8A6Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Seizure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.182658001; Fold-change: -0.008784825; Z-score: -0.029543633 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lateral sclerosis [ICD-11: 8B60.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.908428841; Fold-change: 0.038060892; Z-score: 0.146849167 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Cervical spinal cord | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.046919751; Fold-change: 0.112954517; Z-score: 1.09880085 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Muscular atrophy [ICD-11: 8C70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Muscular atrophy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.297465848; Fold-change: -0.14429818; Z-score: -0.54405598 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myopathy [ICD-11: 8C70.6]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Myopathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.069433026; Fold-change: 0.125000643; Z-score: 1.145116703 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.